35803241 34323288 35107170 36031641 34711671 34185884 35635627 34982496 35835160 35231672 36009152 - Search Results

Year	Number of Results
2021	3
2022	10
2023	0

1

Breaking down a gut-to-brain circuit that prevents malabsorption.

Jarvie BC, Knight ZA. Jarvie BC, et al. Cell. 2022 Jul 7;185(14):2393-2395. doi: 10.1016/j.cell.2022.06.012. Cell. 2022. PMID: 35803241

2

Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment.

Trapp S, Brierley DI. Trapp S, et al. Br J Pharmacol. 2022 Feb;179(4):557-570. doi: 10.1111/bph.15638. Epub 2021 Aug 28. Br J Pharmacol. 2022. PMID: 34323288 Free PMC article. Review.

3

New developments in the prospects for GLP-1 therapy.

Trapp S, Stanford SC. Trapp S, et al. Br J Pharmacol. 2022 Feb;179(4):489-491. doi: 10.1111/bph.15788. Br J Pharmacol. 2022. PMID: 35107170 Free PMC article. No abstract available.

4

Signaling pathways in obesity: mechanisms and therapeutic interventions.

Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, Xu X, Li T. Wen X, et al. Signal Transduct Target Ther. 2022 Aug 28;7(1):298. doi: 10.1038/s41392-022-01149-x. Signal Transduct Target Ther. 2022. PMID: 36031641 Free PMC article. Review.

5

Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture.

Holst JJ. Holst JJ. Diabetes. 2021 Nov;70(11):2468-2475. doi: 10.2337/dbi21-0026. Diabetes. 2021. PMID: 34711671 Free PMC article.

6

Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating.

Brierley DI, de Lartigue G. Brierley DI, et al. Br J Pharmacol. 2022 Feb;179(4):584-599. doi: 10.1111/bph.15603. Epub 2021 Jul 31. Br J Pharmacol. 2022. PMID: 34185884 Free PMC article. Review.

7

Discovery of the GI Effects of GLP-1: An Historical Perspective.

Holst JJ. Holst JJ. Dig Dis Sci. 2022 Jul;67(7):2716-2720. doi: 10.1007/s10620-022-07519-3. Epub 2022 May 30. Dig Dis Sci. 2022. PMID: 35635627 Review.

8

Glucagon-like peptide-1: Are its roles as endogenous hormone and therapeutic wizard congruent?

Holst JJ. Holst JJ. J Intern Med. 2022 May;291(5):557-573. doi: 10.1111/joim.13433. Epub 2022 Jan 24. J Intern Med. 2022. PMID: 34982496 Review.

9

Metabolic effects of truncal vagotomy when combined with bariatric-metabolic surgery.

Kapralou AN, Chrousos GP. Kapralou AN, et al. Metabolism. 2022 Oct;135:155263. doi: 10.1016/j.metabol.2022.155263. Epub 2022 Jul 11. Metabolism. 2022. PMID: 35835160

10

GLP-1 - Incretin and pleiotropic hormone with pharmacotherapy potential. Increasing secretion of endogenous GLP-1 for diabetes and obesity therapy.

Holst JJ, Jepsen SL, Modvig I. Holst JJ, et al. Curr Opin Pharmacol. 2022 Apr;63:102189. doi: 10.1016/j.coph.2022.102189. Epub 2022 Feb 26. Curr Opin Pharmacol. 2022. PMID: 35231672 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results